To amend title XXVII of the Public Health Service Act and the Patient Protection and Affordable Care Act to provide for certain reforms with respect to medical loss ratios and reducing fraudulent enrollment in qualified health plans.
Summary
HR7861 (Care Over Profits Act) proposes raising the minimum MLR from 80% to 85% for individual/small group health plans. The bill is early-stage, referred to committee, and faces long odds, with only one cosponsor and no companion in the Senate. Despite the bearish direct impact on insurer margins, major health insurer stocks have rallied 7-40% over the past 30 days, indicating the market is not pricing in legislative risk.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.HR7861 is early-stage, single-cosponsor bill with very low passage probability in current session
- 2.If enacted, would compress margins on individual/small group lines for insurers like $ELV, $CI, $HUM
- 3.Current stock rallies of 7-40% over 30 days indicate the market is ignoring the legislative risk entirely
- 4.Elevance Health has the highest exposure among the three major insurers analyzed
Market Implications
The sharp rallies in $ELV ($371.61), $CI ($285.75), and $HUM ($241.25) over the past 30 days suggest the market is focused on other fundamentals — possibly rate approvals, enrollment growth, or sector rotation — and is not pricing in HR7861. For investors, this creates a potential asymmetry: if the bill unexpectedly gains committee traction, these stocks could face a 3-8% headline-driven pullback. However, given the early-stage status and long odds, the current rally is likely sustainable on its own merits. Monitor committee scheduling and additional cosponsor additions as leading indicators of true risk.
Full Analysis
-
What happened and current status: On March 9, 2026, Rep. Barrett (R-MI) introduced HR7861, the Care Over Profits Act. It was referred to the House Energy and Commerce Committee. With 119th Congress now in its second session and only one cosponsor, the bill is at a very early procedural stage with minimal legislative momentum.
-
The money trail: The bill does NOT authorize or appropriate any government funding. It imposes a regulatory mandate — raising the minimum MLR for individual/small group plans from 80% to 85%. This directly compresses insurer profit margins on those lines of business: for every $100 in premium, an insurer can retain at most $15 for administration/profit instead of $20. The mechanism is a mandatory spending floor, not a government outlay.
-
Structural winners and losers: Losers are health insurers with large individual/small group commercial books. Elevance Health ($ELV) has the highest exposure at ~35% of premiums, followed by Cigna ($CI) at ~15-20%, and Humana ($HUM) at ~5-8%. No clear winners from this bill.
-
Real market data analysis: Despite the bearish legislative risk, the three affected insurers have rallied sharply over the past 30 days: $ELV +26.94%, $CI +7.12%, $HUM +39.13%. These moves suggest the market is pricing in other tailwinds — likely positive earnings reports, 2026 rate approval cycles, or macro rotation into healthcare — rather than assigning probability to HR7861 passage. The 7-day changes (ELV +7.79%, CI +3.66%, HUM +12.08%) show continued momentum.
-
Timeline: The bill requires committee mark-up in House Energy and Commerce, full House vote, Senate companion introduction and passage, then presidential signature. With a single cosponsor and early stage referral, probability of passage in 2026 is very low (<10%). If reintroduced with broader support, it could gain traction in a 120th Congress.
Intelligence Surface
Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures
Some confirming evidence found across public data sources
What the bill does
Mandate: raising minimum medical loss ratio (MLR) from 80% to 85% for individual/small group plans under PHS Act section 2718(b)(1)(A)(ii).
Who must act
Health insurers offering individual and small group plans — specifically Elevance Health's Anthem-branded plans in those markets.
What happens
Insurers must spend at least 85% of premium dollars on medical claims/quality improvement, reducing the maximum allowable administrative overhead and profit margin from 20% to 15% of premiums. For every $100 in premium revenue, the maximum retained for non-medical costs drops from $20 to $15.
Stock impact
Elevance Health generates ~35% of premiums from individual/small group lines (Anthem-branded ACA marketplace and small employer plans). The 5pp reduction in allowable margin on those lines could compress operating earnings by an estimated ~$400-600M annually based on current premium volume, directly reducing EPS if not offset by rate increases or cost efficiencies.
What the bill does
Mandate: raising minimum MLR from 80% to 85% for individual/small group plans under PHS Act section 2718(b)(1)(A)(ii).
Who must act
Cigna's Cigna Healthcare segment, specifically individual and small group market plans (Cigna's ACA exchange and small business offerings).
What happens
Cigna must reduce administrative/retained margin from 20% to 15% on individual/small group premiums, compressing profitability per member per month on those lines.
Stock impact
Cigna's individual/small group exposure is smaller than Elevance's — approximately 15-20% of total medical premiums. The MLR mandate directly reduces margin on that book; however, Cigna's larger employer-based and stop-loss business (where MLR requirements differ) provides a buffer. Estimated earnings headwind of ~$100-200M annually.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
Veteran Caregiver Reeducation, Reemployment, and Retirement Act
To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes.
Association Health Plans Act
Medicare for All Act
Medicare Advantage Prompt Pay Act
Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act]
Veterans’ ACCESS Act of 2025
Protecting Health Care and Lowering Costs Act
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Implementing Schedule Policy/Career in the Excepted Service
This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.
Realigning United States Core Childhood Vaccine Recommendations with Best Practices from Peer, Developed Countries
This executive order directs the CDC and ACIP to review and potentially update the U.S. childhood vaccine schedule to align with recommendations from peer developed countries, which recommend fewer vaccines. It maintains insurance coverage for all currently available vaccines without cost sharing and emphasizes protecting religious liberty and parental authority.
Promoting Efficiency, Accountability, and Performance in Federal Contracting
This executive order mandates that federal agencies default to using fixed-price contracts for procurement, shifting away from cost-reimbursement models. It requires written justification and senior-level approval for any non-fixed-price contract over certain dollar thresholds (e.g., $10M for most agencies, $100M for the Department of War), and directs agencies to review and renegotiate their 10 largest non-fixed-price contracts within 90 days. The order also tasks OMB with implementation guidance and the Federal Acquisition Regulatory Council with proposing regulatory amendments within 120 days.